| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000008372 |
| Receipt No. | R000009827 |
| Official scientific title of the study | Useflness of LigaSure and Harmonic in liver transection |
| Date of disclosure of the study information | 2012/07/06 |
| Last modified on | 2017/01/08 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Useflness of LigaSure and Harmonic in liver transection | |
| Title of the study (Brief title) | Useflness of LigaSure and Harmonic in liver transection | |
| Region |
|
|
| Condition | |||
| Condition | Primary malignant liver tumor including hepatocellular carcinoma, intrahepatic bile duct cancer, combined hepatocellular-cholangiocarcinoma. Metastatic liver tumor. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the usefulness of LigaSure and Harmonic in liver transection. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Amount of bleeding during liver transection |
| Key secondary outcomes | Total transection time, Cross-sectional area per minute, Operative duration, Postoperative complications, Postoperative liver function, Length of hospital stay |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | |||
| No. of arms | 3 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | In the intervention group, the liver transection is performed using LigaSure. | ||
| Interventions/Control_2 | In the intervention group, the liver transection is performed using Harmonic. | ||
| Interventions/Control_3 | In the control group, the liver transection is performed using conventional clamp crushing method. | ||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients who will undergo hepatic resection for malignant liver tumor
2)ECOG Performance Status 0-2 3)Patients who meet the Makuuchi criteria |
|||
| Key exclusion criteria | 1)Donor of liver transplantation
2)Patients who will undergo biliary tract reconstruction 3)Patients who will undergo resection of the gastrointestinal tract at the same time 4)Patients with simultaneous double cancer 5)When the clamping of hepatoduodenal ligament is expected to be difficult 6)Possibility of exploratory laparotomy 7)Patients with severe complications 8)Patients who were deemed inappropriate for medical reasons |
|||
| Target sample size | 350 | |||
| Research contact person | |
| Name of lead principal investigator | Norihiro Kokudo |
| Organization | The University of Tokyo |
| Division name | Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3815-5411 |
| kokudo-2su@h.u-tokyo.ac.jp | |
| Public contact | |
| Name of contact person | Akihiko Ichida, Kiyoshi Hasegawa |
| Organization | The University of Tokyo |
| Division name | Hepato-biliary-pnacreatic Surgery Division, Department of Surgery, Graduate School of Medicine |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3815-5411 |
| Homepage URL | |
| ichida-tky@umin.ac.jp | |
| Sponsor | |
| Institute | Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funded |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Department of Gastrointestinal Surgery, Nihon University |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医学部附属病院(東京都)、日本大学医学部附属板橋病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009827 |